SCHEMBL21367571

SCHEMBL21367571

O=C(OCc1ccccc1)C(=O)c1ccccc1O

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 4/20 0.70
ALDH1A1 P00352 6/20 0.53
MAPK1 P28482 2/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
LMNA P02545 1/20 0.49
SLC6A2 P23975 1/20 0.49
SLC6A3 Q01959 1/20 0.49
KMT2A Q03164 1/20 0.49
POLB P06746 1/20 0.48
TSHR P16473 2/20 0.47
CA1 P00915 3/20 0.47
CA9 Q16790 3/20 0.47
CA12 O43570 2/20 0.47
CA2 P00918 2/20 0.47
HPGD P15428 2/20 0.47
KDM4E B2RXH2 1/20 0.47
HMGB1 P09429 1/20 0.47
CA4 P22748 1/20 0.47
CA6 P23280 1/20 0.47
CA7 P43166 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27852153 0.83 TDP1 (0.66) TDP1ALDH1A1MAPK1L3MBTL1LMNA
Benzyl Salicylate SCHEMBL1871397 0.82 TDP1 (1.00) TDP1ALDH1A1MAPK1L3MBTL1LMNA
Benzyl Salicylate SCHEMBL15573 0.82 TDP1 (1.00) TDP1ALDH1A1MAPK1L3MBTL1LMNA
Benzyl Salicylate SCHEMBL30184766 0.82 TDP1 (1.00) TDP1ALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL2704242 0.81 ALDH1A1 (0.53) TDP1ALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL22192829 0.81 ALDH1A1 (0.54) TDP1ALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL13595553 0.81 CES2 (0.55) TDP1ALDH1A1MAPK1L3MBTL1LMNA
Benzyl Salicylate SCHEMBL27731147 0.81 TDP1 (0.96) TDP1ALDH1A1MAPK1L3MBTL1LMNA
Benzyl Salicylate SCHEMBL7199160 0.81 TDP1 (0.96) TDP1ALDH1A1MAPK1L3MBTL1LMNA
SCHEMBL25552709 0.80 ALDH1A1 (0.50) TDP1ALDH1A1MAPK1L3MBTL1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230135635-A1 INHIBITORS OF ULK1/2 AND METHODS OF USING SAME Sanford Burnham Prebys Medical Discovery Institute 2023-05-04 US disclosed
US-20230135635-A1 INHIBITORS OF ULK1/2 AND METHODS OF USING SAME Sanford Burnham Prebys Medical Discovery Institute 2023-05-04 US disclosed
WO-2021163629-A1 INHIBITORS OF ULK1/2 AND METHODS OF USING SAME SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2021-08-19 WO disclosed
US-20190284371-A1 FUNCTIONALIZED ORGANOSULFUR COMPOUND FOR REDUCING HYSTERESIS IN A RUBBER ARTICLE SI GROUP, INC. 2019-09-19 US disclosed
WO-2019178373-A1 PHENOLIC RESIN COMPOSITION AND THE USE THEREOF IN A RUBBER COMPOSITION TO REDUCE HYSTERESIS SI GROUP, INC. (US) 2019-09-19 WO disclosed
WO-2019178381-A1 FUNCTIONALIZED ORGANOSULFUR COMPOUND FOR REDUCING HYSTERESIS IN A RUBBER ARTICLE SI GROUP, INC. (US) 2019-09-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230135635-A1 INHIBITORS OF ULK1/2 AND METHODS OF USING SAME ULK2, ULK1, ULK3 TDP1 607/4885ALDH1A1 4012/4885MAPK1 2263/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.